Genome-Wide Association of Familial Late-Onset Alzheimer's Disease Replicates and and Nominates in Interaction with

English version České info

Late-onset Alzheimer's disease (LOAD) is the most common form of dementia in the elderly. The National Institute of Aging-Late Onset Alzheimer's Disease Family Study and the National Cell Repository for Alzheimer's Disease conducted a joint genome-wide association study (GWAS) of multiplex LOAD families (3,839 affected and unaffected individuals from 992 families plus additional unrelated neurologically evaluated normal subjects) using the 610 IlluminaQuad panel. This cohort represents the largest family-based GWAS of LOAD to date, with analyses limited here to the European-American subjects. SNPs near APOE gave highly significant results (e.g., rs2075650, p = 3.2×10⁻⁸¹), but no other genome-wide significant evidence for association was obtained in the full sample. Analyses that stratified on APOE genotypes identified SNPs on chromosome 10p14 in CUGBP2 with genome-wide significant evidence for association within APOE ε4 homozygotes (e.g., rs201119, p = 1.5×10⁻⁸). Association in this gene was replicated in an independent sample consisting of three cohorts. There was evidence of association for recently-reported LOAD risk loci, including BIN1 (rs7561528, p = 0.009 with, and p = 0.03 without, APOE adjustment) and CLU (rs11136000, p = 0.023 with, and p = 0.008 without, APOE adjustment), with weaker support for CR1. However, our results provide strong evidence that association with PICALM (rs3851179, p = 0.69 with, and p = 0.039 without, APOE adjustment) and EXOC3L2 is affected by correlation with APOE, and thus may represent spurious association. Our results indicate that genetic structure coupled with ascertainment bias resulting from the strong APOE association affect genome-wide results and interpretation of some recently reported associations. We show that a locus such as APOE, with large effects and strong association with disease, can lead to samples that require appropriate adjustment for this locus to avoid both false positive and false negative evidence of association. We suggest that similar adjustments may also be needed for many other large multi-site studies.

Vyšlo v časopise: Genome-Wide Association of Familial Late-Onset Alzheimer's Disease Replicates and and Nominates in Interaction with. PLoS Genet 7(2): e32767. doi:10.1371/journal.pgen.1001308
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1001308

Souhrn

Zdroje

1. MayeuxR

2003 Epidemiology of neurodegeneration. Annu Rev Neurosci 26 81 104

2. FratiglioniL

De RonchiD

Aguero-TorresH

1999 Worldwide prevalence and incidence of dementia. Drugs & Aging 15 365 375

3. GatzM

ReynoldsCA

FratiglioniL

JohanssonB

MortimerJA

2006 Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 63 168 174

4. BergemALM

LannfeltL

1997 Apolipoprotein E type epsilon 4 allele, heritability and age at onset in twins with Alzheimer's disease. Clin Genet 52 408 413

5. MeyerJM

BreitnerJCS

1998 Multiple threshold model for the onset of Alzheimer's disease in the NAS-NRC twin panel. Am J Med Genet 81 92 97

6. AkessonHO

1969 A Population Study of Senile and Arteriosclerotic Psychoses. Hum Hered 19 546

7. BreitnerJCS

FolsteinMF

MurphyEA

1986 Familial Aggregation in Alzheimer Dementia .1. a Model for the Age-Dependent Expression of an Autosomal Dominant Gene. J Psychiatr Res 20 31 43

8. MohsRC

BreitnerJCS

SilvermanJM

DavisKL

1987 Alzheimers-Disease - Morbid Risk among 1st-Degree Relatives Approximates 50-Percent by 90 Years of Age. Arch Gen Psychiatry 44 405 408

9. LautenschlagerNT

CupplesLA

RaoVS

AuerbachSA

BeckerR

1996 Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old? Neurology 46 641 650

10. Van BroeckhovenC

GentheAM

Van den BergheA

HorsthemkeB

BackhovensH

1987 Failure of Familial Alzheimers-Disease to Segregate with the A4-Amyloid Gene in Several European Families. Nature 329 153 155

11. BirdTD

LampeTH

NemensEJ

MinerGW

SumiSM

1988 Familial Alzheimer's disease in american descendants of the Volga Germans: probable genetic founder effect. Ann Neurol 23 25 31

12. St. George-HyslopPH

MyersRH

HainesJL

FarrerLA

TanziRE

1989 Familial Alzheimers-Disease - Progress and Problems. Neurobiol Aging 10 417 425

13. GoateA

Chartier-HarlinMC

MullanM

BrownJ

CrawfordF

1991 Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349 704 706

14. SherringtonR

RogaevEI

LiangY

RogaevaEA

LevesqueG

1995 Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375 754 760

15. Levy-LahadE

WascoW

PoorkajP

RomanoDM

OshimaJ

1995 Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269 973 977

16. CorderEH

SaundersAM

StrittmatterWJ

SchmechelDE

GaskellPC

1993 Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 921 923

17. CorderEH

SaundersAM

RischNJ

StrittmatterWJ

SchmechelDE

1994 Protective Effect of Apolipoprotein-E Type-2 Allele for Late-Onset Alzheimer-Disease. Nat Genet 7 180 184

18. MyersRH

SchaeferEJ

WilsonPWF

DagostinoR

OrdovasJM

1996 Apolipoprotein E epsilon 4 association with dementia in a population-based study: The Framingham study. Neurology 46 673 677

19. BennettCL

CrawfordF

OsborneA

DiazP

HoyneJ

1995 Evidence that the APOE locus influences rate of disease progression in late-onset familial Alzheimer's-disease but is not causative. Am J Med Genet B Neuropsychiatr Genet 50 1 6

20. SlooterAJC

CrutsM

KalmijnS

HofmanA

BretelerMMB

1998 Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: The Rotterdam study. Arch Neurol 55 964 968

21. DawEW

HeathSC

WijsmanEM

1999 Multipoint oligogenic analysis of age-at-onset data with applications to Alzheimer's disease pedigrees. Am J Hum Genet 64 839 851

22. DawEW

PayamiH

NemensEJ

NochlinD

BirdTD

2000 The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet 66 196 204

23. Pericak-VanceMA

GrubberJM

BaileyLR

HedgesD

WestS

2000 Identification of Novel Genes in Late-Onset Alzheimer's Disease. Exp Gerontol 35 1343 1352

24. BlackerD

BertramL

SaundersAJ

MoscarilloTJ

AlbertMS

2003 Results of a high-resolution genome screen of 437 Alzheimer's Disease families. Hum Mol Genet 12 23 32

25. FarrerLA

BowirratA

FriedlandRP

WaraskaK

KorczynAD

2003 Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community. Hum Mol Genet 12 415 422

26. ScottWK

HauserER

SchmechelDE

Welsh-BohmerKA

SmallGW

2003 Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22. Am J Hum Genet 73 1041 1051

27. WijsmanEM

DawEW

YuCE

PayamiH

SteinbartEJ

2004 Evidence for a novel late-onset Alzheimer's disease locus on chromosome 19p13.2. Am J Hum Genet 75 398 409

28. BertramL

HiltunenM

ParkinsonM

IngelssonM

LangeC

2005 Family-based association between Alzheimer's disease and variants in UBQLN1. N Engl J Med 352 884 894

29. RademakersR

CrutsM

SleegersK

DermautB

TheunsJ

2005 Linkage and association studies identify a novel locus for Alzheimer disease at 7q36 in a Dutch population-based sample. Am J Hum Genet 77 643 652

30. HahsDW

McCauleyJL

CrunkAE

McFarlandLL

GaskellPC

2006 A genome-wide linkage analysis of dementia in the Amish. Am J Med Genet B Neuropsychiatr Genet 141B 160 166

31. LeeJH

ChengR

SantanaV

WilliamsonJ

LantiguaR

2006 Expanded genomewide scan implicates a novel locus at 3q28 among Caribbean Hispanics with familial Alzheimer disease. Arch Neurol 63 1591 1598

32. LiY

GrupeA

RowlandC

NowotnyP

KauweJS

2006 DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. Hum Mol Genet 15 2560 2568

33. ButlerAW

NgMYM

HamshereML

ForaboscoP

WroeR

2009 Meta-analysis of linkage studies for Alzheimer's disease-A web resource. Neurobiol Aging 30 1037 1047

34. CoonKD

MyersAJ

CraigDW

WebsterJA

PearsonJV

2007 A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry 68 613 618

35. GrupeA

AbrahamR

LiY

RowlandC

HollingworthP

2007 Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. Hum Mol Genet 16 865 873

36. ReimanEM

WebsterJA

MyersAJ

HardyJ

DunckleyT

2007 GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron 54 713 720

37. AbrahamR

MoskvinaV

SimsR

HollingworthP

MorganA

2008 A genome-wide association study for late-onset Alzheimer's disease using DNA pooling. BMC Medical Genomics 1 44

38. BertramL

LangeC

MullinK

ParkinsonM

HsiaoM

2008 Genome-wide Association Analysis Reveals Putative Alzheimer's Disease Susceptibility Loci in Addition to APOE. Am J Hum Genet 83 623 632

39. BeechamGW

MartinER

LiYJ

SliferMA

GilbertJR

2009 Genome-wide Association Study Implicates a Chromosome 12 Risk Locus for Late-Onset Alzheimer Disease. Am J Hum Genet 84 35 43

40. CarrasquilloMM

ZouFG

PankratzVS

WilcoxSL

MaL

2009 Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease. Nat Genet 41 192 198

41. PodusloSE

HuangR

HuangJ

SmithS

2009 Genome screen of late-onset Alzheimer's extended pedigrees identifies TRPC4AP by haplotype analysis. Am J Med Genet B Neuropsychiatr Genet 150B 50 55

42. HaroldD

AbrahamR

HollingworthP

SimsR

GerrishA

2009 Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 62 1088 1093

43. LambertJC

HeathS

EvenG

CampionD

SleegersK

2009 Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41 1094 1099

44. SeshadriS

FitzpatrickAL

IkramMA

DeStefanoAL

GudnasonV

2010 Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease. JAMA 303 1832 1840

45. ZhongH

PrenticeRL

2010 Correcting “‘Winner's Curse” in Odds Ratios from Genomewide Association Findings for Major Complex Human Diseases. Genet Epidemiol 34 78 91

46. JarvikGP

LarsonEB

GoddardKAB

SchellenbergGD

WijsmanEM

1996 Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample. Am J Hum Genet 58 191 200

47. SlooterAJC

vanDuijnCM

1997 Genetic epidemiology of Alzheimer disease. Epidemiol Rev 19 107 119

48. McCarthyM

KruglyakL

LanderE

1998 Sib-pair collection strategies for complex diseases. Genet Epidemiol 15 317 340

49. McKhannG

DrachmanD

FolsteinM

KatzmanR

PriceD

1984 Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 939 944

50. PetersenRC

SmithGE

WaringSC

IvnikRJ

TangalosEG

1999 Mild cognitive impairment - Clinical characterization and outcome. Arch Neurol 56 303 308

51. HughesCP

BergL

DanzigerWL

CobenLA

MarginRL

1982 A new clinical scale for the staging of dementia. Br J Psychiatry 140 566 572

52. MirraSS

HeymanA

McKeelD

SumiSM

CrainBJ

1991 The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 479 486

53. ChudykA

MasiukM

MyslakM

DomanskiL

SienkoJ

2006 Soluble HLA class I molecules exert differentiated influence on renal graft condition. Transplant Proc 38 90 93

54. MyakishevMV

KhripinY

HuS

HamerDH

2001 High-throughput SNP genotyping by allele-specific PCR with universal energy-transfer-labeled primers. Genome Res 11 163 169

55. HawkinsJR

KhripinY

ValdesAM

WeaverTA

2002 Miniaturized sealed-tube allele-specific PCR. Hum Mutat 19 543 553

56. BekrisLM

MillardSP

GallowayNM

VuleticS

AlbersJJ

2008 Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels. J Alzheimers Dis 13 255 266

57. PotkinSG

GuffantiG

LakatosA

TurnerJA

KruggelF

2009 Hippocampal Atrophy as a Quantitative Trait in a Genome-Wide Association Study Identifying Novel Susceptibility Genes for Alzheimer's Disease. PLoS ONE 4 e6501 doi:10.1371/journal.pone.0006501

58. RosesAD

2010 An Inherited Variable Poly-T Repeat Genotype in TOMM40 in Alzheimer Disease. Arch Neurol 67 536 541

59. GöringHHH

OttJ

1997 Relationship estimation in affected rib pair analysis of late-onset diseases. Eur J Hum Genet 5 69 77

60. SunL

WilderK

McPeekMS

2002 Enhanced pedigree error detection. Hum Hered 54 99 110

61. NielsenDM

EhmMG

WeirBS

1998 Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus. Am J Hum Genet 63 1531 1540

62. Wittke-ThompsonJK

PluzhnikovA

CoxNJ

2005 Rational inferences about departures from Hardy-Weinberg equilibrium. Am J Hum Genet 76 967 986

63. ZouGY

DonnerA

2006 The merits of testing Hardy-Weinberg equilibrium in the analysis of unmatched case-control data: A cautionary note. Ann Hum Genet 70 923 933

64. PriceAL

PattersonNJ

PlengeRM

WeinblattME

ShadickNA

2006 Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38 904 909

65. PriceAL

ButlerJ

PattersonN

CapelliC

PascaliVL

2008 Discerning the ancestry of European Americans in genetic association studies. PLoS Genet 4 e236 doi:10.1371/journal.pgen.0030236

66. HarveyCB

HolloxEJ

PoulterM

WangY

RossiM

1998 Lactase haplotype frequencies in Caucasians: association with the lactase persistence/non-persistence polymorphism. Ann Hum Genet 62 215 223

67. HolloxEJ

PoulterM

ZvarikM

FerakV

KrauseA

2001 Lactase haplotype diversity in the Old World. Am J Hum Genet 68 160 172

68. ChoiY

WijsmanEM

WeirBS

2009 Case-control Association Testing in the Presence of Unknown Relationships. Genet Epidemiol 35 668 678

69. JacquardA

1972 Genetic Information Given by a Relative. Biometrics 28 1101 1114

70. MilliganBG

2003 Maximum-likelihood estimation of relatedness. Genetics 163 1153 1167

71. BourgainC

HoffjanS

NicolaeR

NewmanD

SteinerL

2003 Novel case-control test in a founder population identifies P-selectin as an atopy-susceptibility locus. Am J Hum Genet 73 612 626

72. PritchardJK

DonnellyP

2001 Case-control studies of association in structured or admixed populations. Theor Popul Biol 60 227 237

73. FarrerLA

CupplesLA

HainesJL

HymanB

KukullWA

1997 Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278 1349 1356

74. DevlinB

RoederK

1999 Genomic control for association studies. Biometrics 55 997 1004

75. ChapmanJM

CooperJD

ToddJA

ClaytonD

2003 Detecting disease associations due to linkage disequilibrium using haplotype tags: A class of tests and the determinants of statistical power. Hum Hered 56 18 31

76. YuCE

SeltmanH

PeskindER

GallowayN

ZhouPX

2007 Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: Patterns of linkage disequilibrium and disease/marker association. Genomics 89 655 665

77. CruchagaC

KauweJSK

MayoK

SpiegelN

BertelsenS

2010 SNPs Associated with Cerebrospinal Fluid Phospho-Tau Levels Influence Rate of Decline in Alzheimer's Disease. PLoS Genet 6 e1001101 doi:10.1371/journal.pgen.1001101

78. TangMX

SternY

MarderK

BellK

GurlandB

1998 The APOE-epsilon 4 allele and the risk of Alzheimer disease among African Americans, Whites, and Hispanics. JAMA 279 751 755

79. RomasSN

SantanaV

WilliamsonJ

CiappaA

LeeJH

2002 Familial Alzheimer disease among Caribbean Hispanics - A reexamination of its association with APOE. Arch Neurol 59 87 91

80. RosenbergNA

VanLiereJM

2009 Replication of Genetic Associations as Pseudoreplication due to Shared Genealogy. Genet Epidemiol 33 479 487

81. HeathSC

GutIG

BrennanP

McKayJD

BenckoV

2008 Investigation of the fine structure of European populations with applications to disease association studies. Eur J Hum Genet 16 1413 1429

82. LucotteG

LoiratF

HazoutS

1997 Pattern of gradient of apolipoprotein E allele *4 frequencies in Western Europe. Hum Biol 69 253 262

83. CorboRM

ScacchiR

1999 Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrifty’ allele? Ann Hum Genet 63 301 310

84. SinghPP

SinghM

MastanaSS

2006 APOE distribution in world populations with new data from India and the UK. Ann Hum Biol 33 279 308

85. RosenmannH

MeinerZ

KahanaE

AladjemZ

FriedmanG

2003 An association study of the codon 72 polymorphism in the pro-apoptotic gene p53 and Alzheimer's disease. Neurosci Lett 340 29 32

86. Dresner-PollakR

KinnarT

FriedlanderY

SharonN

RosenmannH

2009 Estrogen Receptor Beta Gene Variant Is Associated with Vascular Dementia in Elderly Women. Genet Test Mol Biomarkers 13 339 342

87. LittleJ

HigginsJPT

IoannidisJPA

MoherD

GagnonF

2009 Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum Genet 125 131 151

88. NelisM

EskoT

MagiR

ZimprichF

ZimprichA

2009 Genetic Structure of Europeans: A View from the North-East. PLoS ONE 4 e5472 doi:10.1371/journal.pone.0005472

89. ZekraouiL

LagardeJP

RaisonnierA

GerardN

AouizerateA

1997 High frequency of the apolipoprotein E *4 allele in African pygmies and most of the African populations in sub-Saharan Africa. Hum Biol 69 575 581

90. VoightBF

PritchardJK

2005 Confounding from cryptic relatedness in case-control association studies. PLoS Genet 1 e32 doi:10.1371/journal.pgen.0010032

91. BhattacharjeeS

WangZ

CiampaJ

KraftP

ChanockS

2010 Using Principal Components of Genetic Variation for Robust and Powerful Detection of Gene-Gene Interactions in Case-Control and Case-Only Studies. Am J Hum Genet 86 331 342

92. BlackerD

BertramL

SaundersAJ

MoscarilloTJ

AlbertMS

2001 Results of a high resolution genome screen in 443 Alzheimer's disease families: the NIMH Genetics Initiative. Am J Hum Genet 69 498 498

93. LeeJH

ChengR

Graff-RadfordN

ForoudT

MayeuxR

2008 Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study Implication of Additional Loci. Arch Neurol 65 1518 1526

94. PastorP

RoeC

VillegasA

BedoyaG

ChakravertyS

2003 Apolipoprotein E ε4 modifies Alzheimer's disease onset in an E280A PS1 Kindred. Ann Neurol 54 163 169

95. WijsmanEM

DawEW

YuX

SteinbartEJ

NochlinD

2005 APOE and other loci affect age-at-onset in Alzheimer's disease families with PS2 mutation. Am J Med Genet B Neuropsychiatr Genet 132B 14 20

96. MarchaniEE

BirdTD

SteinbartEJ

RosenthalE

YuCE

2010 Evidence for three loci modifying age-at-onset of Alzheimer's disease in early-onset PSEN2 families. Am J Med Genet B Neuropsychiatr Genet 153B 1031 1041

97. PaciniA

ToscanoA

CesatiV

CozziA

MeliE

2005 NAPOR-3 RNA binding protein is required for apoptosis in hippocampus. Brain Res Mol Brain Res 140 34 44

98. FalkevallA

AlikhaniN

BhushanS

PavlovPF

BuschK

2006 Degradation of the amyloid beta-protein by the novel mitochondrial peptidasome, PreP. J Biol Chem 281 29096 29104

99. JunG

NajAC

BeechamGW

WangLS

BurosJ

2010 Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol Sept. 3 Epub ahead of print

100. CarrasquilloMM

BelbinO

HunterTA

MaL

BisceglioGD

2010 Replication of CLU, CR1, and PICALM Associations With Alzheimer Disease. Arch Neurol 67 961 964

101. WakefieldJ

2009 Bayes Factors for Genome-Wide Association Studies: Comparison with P-values. Genet Epidemiol 33 79 86